Multicenter Automatic Defibrillator Implantation Trial- Chemotherapy Induced Cardiomyopathy
A study for patients with impaired heart function using a cardiac device to pace the heart more efficiently
Sponsor: University of Rochester
Enrolling: Male and Female Patients
IRB Number: AAAN4005
U.S. Govt. ID: NCT02164721
Contact: Gregg Rosner MD: 1 212 342 3820 / gfr2107@cumc.columbia.edu
Additional Study Information: The purpose of this trial is to determine if people with impaired heart function, that may have been induced with chemotherapeutic drugs and/or radiation, will have improved heart function with a cardiac device that can pace the heart more efficiently using cardiac resynchronization therapy.
This study is closed
Investigator
Gregg Rosner, MD
Do You Qualify?
Do you have a currently implanted pacemaker or implantable cardioverter defibrillator (ICD) device? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder




For more information, please contact:
Gregg Rosner MD
gfr2107@cumc.columbia.edu
1 212 342 3820